Gene name | Probeset ID | Probeset number | Exon number | Fs scorea | F0 scoreb | FDRc | DEd |
---|
Rcan1 | 4567413 | 4 | 3 | 444.6 | 0.345 | 0.0 | − |
Dclk1 | 5144145 | 10 | 9 | 96.8 | 0.525 | 0.0 | − |
Mt1 | 5480425 | 1 | 2 | 70.9 | 0.621 | 0.0 |  +  |
Vmp1 | 4780502 | 11 | 13 | 50.1 | 0.542 | 0.0 | − |
Ntf3 | 5239597 | 7 | 3 | 14.8 | 0.371 | 0.067 |  +  |
Rheb | 5489435 | 8 | 8 | 15.1 | 0.404 | 0.071 |  +  |
Grik2 | 5235346 | 9 | 8 | 15.5 | 121.96 | 0.077 |  +  |
Car2 | 4363942 | 22 | 13 | 16.1 | 0.347 | 0.083 | − |
Homer1 | 5397705 | 6 | 2 | 161.6 | 0.581 | 0.091 |  +  |
Nav2 | 4655500 | 3 | 9 | 169.6 | 0.841 | 0.1 | − |
- FIRMA (F) scores represent the discrepancy of one probeset from the other probesets in the same gene and were calculated for every probeset and sample
- Italics indicates genes also found highly significantly spliced using time-dependent ANOSVA (Table 1)
- aFs score, corresponds to samples collected after seizure compared to controls and samples
- bF0 score, corresponds to samples collected after vehicle treatment compared to controls
- cFDR, False discovery rate calculated from F scores for the alternative and the null model
- dDE, differentially expressed, indicates whether the whole gene was identified as induced by neuronal activity in our initial analysis (Table S1)